<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Liver transplantation in adults: Endoscopic management of biliary adverse events
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Liver transplantation in adults: Endoscopic management of biliary adverse events
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Liver transplantation in adults: Endoscopic management of biliary adverse events
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Andrés Cárdenas, MD, PhD, MMSc, AGAF, FAASLD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karen L Krok, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul J Thuluvath, MBBS, MD, FRCP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Douglas G Adler, MD, FACG, AGAF, FASGE
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 21, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Liver transplantation (LT) is performed for patients with decompensated cirrhosis, hepatocellular carcinoma, and/or acute liver failure. Biliary tract adverse events including biliary strictures and bile leaks may contribute to patient morbidity and limited graft survival. Most biliary adverse events can be managed with interventional endoscopic retrograde cholangiopancreatography (ERCP) for LT recipients with duct-to-duct biliary anastomosis. Some LT recipients with Roux-en-Y anastomosis can also be managed endoscopically. (See
         <a class="medical medical_review" href="/z/d/html/15864.html" rel="external">
          "ERCP in patients with Roux-en-Y anatomy"
         </a>
         .)
        </p>
        <p>
         This topic will discuss endoscopic management of biliary adverse events related to LT. Medical care of the LT recipient is discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4589.html" rel="external">
          "Liver transplantation in adults: Long-term management of transplant recipients"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4586.html" rel="external">
          "Liver transplantation in adults: Initial and maintenance immunosuppression"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4588.html" rel="external">
          "Infectious complications in liver transplantation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         An overview of ERCP is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/632.html" rel="external">
          "Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"
         </a>
         .)
        </p>
        <p>
         The prevention and management of infection related to ERCP (eg, cholangitis) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/641.html" rel="external">
          "Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          INCIDENCE AND RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The estimated incidence of biliary adverse events related to LT ranges from 10 to 15 percent in recipients of deceased donor livers and from 15 to 30 percent in recipients of living donor livers [
         <a href="#rid1">
          1-5
         </a>
         ]. Risk factors for biliary adverse events after LT include  (
         <a class="graphic graphic_table graphicRef50456" href="/z/d/graphic/50456.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid2">
          2,6-18
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Donor-related factors – Transplanted liver from a living donor (rather than deceased donor) or a donation after cardiac death donor; older age of donor; high donor body mass index; macrovesicular graft steatosis &gt;25 percent [
         <a href="#rid19">
          19-21
         </a>
         ] (see
         <a class="local">
          'Special populations'
         </a>
         below).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recipient-related factors – History of primary sclerosing cholangitis, cytomegalovirus infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vascular factors – Hepatic artery thrombosis, hepatic artery stenosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Surgical/technical factors – Excessive dissection of periductal tissue during procurement of the liver graft, excessive use of electrocautery for control of biliary ductal bleeding, tension at the anastomosis, small bile duct diameter of the graft, mismatched size between donor and recipient bile ducts, ischemia/reperfusion injury, prolonged cold and/or warm ischemia times.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postoperative factors – Bile leak (via local inflammation and fibrosis) (see
         <a class="local">
          'Bile leaks'
         </a>
         below).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other factors – ABO incompatibility.
        </p>
        <p>
        </p>
        <p>
         Whether the type of biliary reconstruction (duct-to-duct choledochocholedochostomy or Roux-en-Y choledochojejunostomy) increases the risk of biliary adverse events is uncertain [
         <a href="#rid22">
          22-25
         </a>
         ]. However, duct-to-duct anastomosis facilitates endoscopic access to the biliary tree and preserves the sphincter of Oddi, which in theory avoids reflux of luminal contents into the bile duct [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15864.html" rel="external">
          "ERCP in patients with Roux-en-Y anatomy"
         </a>
         .)
        </p>
        <p>
         Historically, T-tube placement was associated with biliary adverse events, but T-tubes are rarely used in most centers that perform liver transplantation [
         <a href="#rid26">
          26-28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H2008628401">
         <span class="h2">
          When to suspect a biliary adverse event
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical presentation of biliary adverse events varies among LT recipients. At one extreme, some patients have asymptomatic elevations in liver enzymes, primarily in a cholestatic pattern (disproportionate elevation of the alkaline phosphatase compared with the aminotransferases) but without abdominal pain, pruritus, or jaundice. (See
         <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">
          "Approach to the patient with abnormal liver biochemical and function tests", section on 'Patterns of liver test abnormalities'
         </a>
         .)
        </p>
        <p>
         However, other patients may present with fever, right upper quadrant abdominal pain, and/or jaundice. Occasionally, other symptoms such as anorexia and pruritus are reported. For patients with a bile leak, exposure of the peritoneum to bile usually results in abdominal pain. However, some patients with bile leak do not have abdominal pain, possibly because of immunosuppression and hepatic denervation [
         <a href="#rid6">
          6,7,25
         </a>
         ]. (See
         <a class="local">
          'Bile leaks'
         </a>
         below.)
        </p>
        <p>
         The evaluation of other suspected hepatobiliary adverse events following liver transplantation (eg, acute T-cell mediated rejection) is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4587.html" rel="external">
          "Liver transplantation in adults: Clinical manifestations and diagnosis of acute T-cell mediated (cellular) rejection of the liver allograft", section on 'Diagnostic evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4589.html" rel="external">
          "Liver transplantation in adults: Long-term management of transplant recipients", section on 'Hepatobiliary complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3686082832">
         <span class="h2">
          Initial testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients suspected of having a biliary adverse event based on symptoms and/or elevated liver enzymes, evaluation begins with a transabdominal liver ultrasound with a Doppler study of the hepatic vessels. Further testing is informed by ultrasound findings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Biliary abnormality
         </strong>
         – If liver ultrasound demonstrates features of bile duct obstruction (eg, biliary ductal dilation) or a fluid collection suggestive of a bile leak, a cholangiogram is usually obtained to confirm the diagnosis, further define the adverse event, and perform an intervention if needed (eg, biliary stent placement) [
         <a href="#rid1">
          1,6,7,18,25,29
         </a>
         ]. For patients with suspected biliary obstruction, the approach to care is outlined in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef56381" href="/z/d/graphic/56381.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Selecting a method for obtaining a cholangiogram is determined by the type of biliary reconstruction, the likelihood of therapeutic intervention, and the available expertise. For patients with a suspected biliary adverse event based on symptoms, laboratory studies, and ultrasound findings (eg, dilated bile duct), ERCP or percutaneous transhepatic cholangiography (PTC) is typically performed. For patients with duct-to-duct anastomosis, we proceed with ERCP for diagnostic confirmation and therapeutic intervention [
         <a href="#rid30">
          30,31
         </a>
         ]. We generally reserve PTC for patients in whom ERCP was unsuccessful and for some patients with a Roux-en-Y choledochojejunostomy. In high-volume centers with experienced advanced endoscopists, ERCP can be successfully performed in some patients with a Roux-en-Y choledochojejunostomy via small bowel enteroscopy [
         <a href="#rid32">
          32-34
         </a>
         ]. Methods for performing ERCP in patients with Roux-en-Y anatomy are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/15864.html" rel="external">
          "ERCP in patients with Roux-en-Y anatomy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The evaluation of biliary adverse events in the LT recipient often includes performing ERCP that is simultaneously diagnostic and therapeutic, although in the nontransplant setting, ERCP is usually reserved for therapeutic indications. (See
         <a class="medical medical_review" href="/z/d/html/632.html" rel="external">
          "Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Indications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vascular abnormality
         </strong>
         – If a vascular abnormality such as hepatic artery stenosis or occlusion is suspected by Doppler study, a computed tomography scan with angiogram is obtained to confirm the diagnosis [
         <a href="#rid35">
          35-37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          No biliary or vascular abnormality
         </strong>
         – Transabdominal ultrasound may not be sufficiently sensitive to detect biliary obstruction (sensitivity of ultrasound, 38 to 66 percent) [
         <a href="#rid10">
          10,38,39
         </a>
         ]. Thus, a normal appearing biliary tree should not preclude further evaluation when a biliary tract adverse event is suspected. For such patients, magnetic resonance cholangiopancreatography (MRCP) is obtained before proceeding with an invasive cholangiogram (ERCP or PTC)  (
         <a class="graphic graphic_diagnosticimage graphicRef53402" href="/z/d/graphic/53402.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         MRCP is preferred for patients in whom ERCP and/or PTC cannot be performed. As examples, ERCP may be unsuccessful in patients with Roux-en-Y choledochojejunostomy and a long Roux limb, and PTC may not be feasible in patients without dilated biliary ducts. (See
         <a class="medical medical_review" href="/z/d/html/671.html" rel="external">
          "Percutaneous transhepatic cholangiography in adults"
         </a>
         .)
         <strong>
         </strong>
        </p>
        <p>
        </p>
        <p>
         MRCP is a reliable, noninvasive technique for detecting biliary adverse events after LT, and its use is supported by society guidelines [
         <a href="#rid31">
          31,40-42
         </a>
         ]. A meta-analysis of 20 studies found that MRCP had a sensitivity of 95 percent and a specificity of 90 percent for diagnosing post-LT biliary strictures [
         <a href="#rid31">
          31
         </a>
         ]. In a study including 165 LT recipients with suspected biliary adverse event, performing ERCP when there was evidence of bile duct obstruction or bile leak on advanced imaging, laboratory tests, or liver biopsy was associated with higher rates of a high-yield endoscopic procedure (ie, one in which a clinically important intervention was needed) compared with diagnostic ERCP (ie, performing ERCP without preprocedure advanced imaging such as MRCP) (90 versus 66 percent) [
         <a href="#rid41">
          41
         </a>
         ]. Rates of serious adverse events were not significantly different between the groups.
        </p>
        <p class="headingAnchor" id="H4074138993">
         <span class="h2">
          Subsequent testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with a suspected biliary adverse event but without evidence of biliary abnormality on transabdominal ultrasound and MRCP, liver biopsy is often performed to exclude acute T-cell mediated rejection (TCMR) or other causes of elevated liver enzymes (eg, recurrence of primary disease). It is important to exclude biliary obstruction with imaging (eg, ultrasound or MRCP) prior to performing liver biopsy because performing liver biopsy in the setting of biliary obstruction may increase the risk of biopsy-related events such as bile leak and peritonitis [
         <a href="#rid43">
          43
         </a>
         ]. (See
         <a class="local">
          'Initial testing'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/3587.html" rel="external">
          "Approach to liver biopsy", section on 'Complications'
         </a>
         .)
        </p>
        <p>
         The clinical features and diagnosis of acute TCMR in the LT recipient are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4587.html" rel="external">
          "Liver transplantation in adults: Clinical manifestations and diagnosis of acute T-cell mediated (cellular) rejection of the liver allograft"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H148027167">
         <span class="h1">
          BILIARY STRICTURES
         </span>
        </p>
        <p class="headingAnchor" id="H3438624138">
         <span class="h2">
          Incidence and risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Biliary strictures account for approximately 40 percent of all biliary adverse events after LT, and they have been classified as anastomotic or non-anastomotic strictures [
         <a href="#rid7">
          7
         </a>
         ]. In a systematic review of 61 studies including over 14,000 liver transplantations, the overall incidence of biliary stricture formation was 13 percent (ie, 12 percent reported among deceased donor recipients and 19 percent among living donor recipients) [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
         Strictures that occur early after LT (eg, within two months after transplantation) are often related to technical problems during surgery, whereas nonearly strictures are mainly due to vascular insufficiency, ischemia, and problems with healing and fibrosis [
         <a href="#rid7">
          7,39
         </a>
         ]. In addition, approximately 20 percent of postoperative bile leaks progress to biliary strictures [
         <a href="#rid15">
          15,45
         </a>
         ]. (See
         <a class="local">
          'Bile leaks'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H148027761">
         <span class="h2">
          Anastomotic strictures
         </span>
        </p>
        <p class="headingAnchor" id="H1903562185">
         <span class="h3">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of anastomotic biliary strictures (ABS) develop between 2 to 12 months after LT, but may occur at any time after LT [
         <a href="#rid46">
          46
         </a>
         ]. ABS have been defined as being single, short, and located within 5 to 10 mm of the biliary anastomosis [
         <a href="#rid47">
          47
         </a>
         ]. On cholangiogram, the stricture typically appears as a thin narrowing in the area of the biliary anastomosis  (
         <a class="graphic graphic_diagnosticimage graphicRef50820 graphicRef63968 graphicRef58463" href="/z/d/graphic/50820.html" rel="external">
          image 2A-C
         </a>
         ).
        </p>
        <p>
         In some patients, a transient narrowing of the anastomosis may become evident within one to two months after LT due to postoperative edema and inflammation [
         <a href="#rid25">
          25
         </a>
         ]. This postoperative narrowing is usually not a true stricture and does not require endoscopic intervention unless liver biochemistries are elevated and a biliary adverse event is suspected. (See
         <a class="local">
          'When to suspect a biliary adverse event'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1164515075">
         <span class="h3">
          Initial intervention
         </span>
        </p>
        <p class="headingAnchor" id="H1001862909">
         <span class="h4">
          Goals
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goals of endoscopic intervention with ERCP are to increase the diameter of the ABS as demonstrated on cholangiography, to improve flow of bile through the anastomosis, and to resolve symptoms and laboratory abnormalities associated with cholestasis (eg, jaundice, cholangitis, elevated liver enzymes) [
         <a href="#rid5">
          5,42,48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H459622475">
         <span class="h4">
          General measures
         </span>
         <span class="headingEndMark">
          —
         </span>
         We administer antibiotic prophylaxis to liver transplant recipients undergoing ERCP who are at risk for incomplete biliary drainage (eg, those with multiple biliary strictures and/or ischemic cholangiopathy)  (
         <a class="graphic graphic_table graphicRef99536" href="/z/d/graphic/99536.html" rel="external">
          table 2
         </a>
         ). General measures for patients undergoing ERCP, including indications for antibiotic prophylaxis, are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/632.html" rel="external">
          "Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2545.html" rel="external">
          "Antibiotic prophylaxis for gastrointestinal endoscopic procedures", section on 'Endoscopic retrograde cholangiopancreatography (ERCP)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3985482342">
         <span class="h4">
          Frequency and number of endoscopic sessions
         </span>
         <span class="headingEndMark">
          —
         </span>
         The total number of endoscopic sessions required for stricture resolution usually depends on timing of stricture development:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Early stricture (within two months after LT) – Early strictures generally respond to one session of endoscopic balloon dilation and/or plastic stent placement. For most patients, the stricture will resolve within three months, and the anastomosis will remain patent without further intervention.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Late stricture (≥2 months after LT) – Most patients with late ABS undergo ERCP with balloon dilation and temporary stenting (ie, 6 to 12 months) with a fully covered, self-expandable metal stent (SEMS) or with plastic biliary stents. Plastic stents are usually exchanged at three-month intervals to avoid increased risk of stent occlusion and bacterial cholangitis. Most patients who undergo ERCP with plastic stent placement require several endoscopic interventions (ie, generally ranging from three to five endoscopic procedures) to achieve stricture resolution [
         <a href="#rid46">
          46,49-62
         </a>
         ]. In contrast, a fully covered SEMS remains in place for approximately six months until it is removed endoscopically [
         <a href="#rid63">
          63-66
         </a>
         ]. (See
         <a class="local">
          'Selecting a stent'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1183242422">
         <span class="h4">
          Selecting a stent
         </span>
         <span class="headingEndMark">
          —
         </span>
         The choice of biliary stent is informed by several factors including location and length of post-transplant ABS, efficacy, risk of stent dysfunction (eg, stent migration, stent occlusion), endoscopist preference, and stent availability. Specific features of biliary stents (ie, material, covering, shape, size) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13925.html" rel="external">
          "Endoscopic stenting for malignant biliary obstruction", section on 'Types of biliary stents'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Distal (extrahepatic) ABS
         </strong>
         – For patients with distal (extrahepatic) ABS who require biliary drainage, we typically place a fully covered SEMS that is 10 mm in diameter and 60 or 80 mm in length. Fully covered SEMS provide effective drainage and require fewer endoscopic procedures than plastic stents, and studies have suggested a shorter time to stricture resolution with metal stenting [
         <a href="#rid59">
          59,63-67
         </a>
         ]. In a systematic review of four trials including 205 patients with ABS after liver transplantation, there were no significant differences in rates of stricture resolution, stricture recurrence, and overall adverse events in patients treated with covered SEMS compared with plastic stents [
         <a href="#rid67">
          67
         </a>
         ]. Metal stents were associated with shorter total duration of stenting (mean difference [MD] -105 days, 95% CI -202 to -8 days) and fewer endoscopic procedures (MD -1.86, 95% CI -3.12 to -0.6). In another systematic review of 10 studies including 200 patients with ABS, covered SEMS placement was associated with stricture resolution rates of 82 percent when the stenting duration was three months or longer [
         <a href="#rid59">
          59
         </a>
         ]. In a subsequent study including 41 patients who were followed for five years after either removal of covered SEMS or observed stent migration, rates for remaining stent-free at five years were 49 percent overall and 61 percent among 31 patients with over four months of covered SEMS indwelling time [
         <a href="#rid68">
          68
         </a>
         ]. In 28 patients with stricture resolution after SEMS removal or observed migration after a median of five months stent indwelling time, the rate of no stricture recurrence at five years was 72 percent. Serious adverse events were reported in 16 patients (39 percent), and the most commonly reported event was cholangitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Proximal ABS
         </strong>
         – For patients with proximal ABS, we typically use plastic stents because covered SEMS may obstruct the right or left bile ducts. Endoscopic therapy with plastic stent placement has been associated with long-term stricture resolution for most patients with ABS [
         <a href="#rid46">
          46,55,58,59,61,62,69,70
         </a>
         ]. In a systematic review of eight studies including 440 patients with ABS, endoscopic therapy with placement of multiple plastic stents for 12 months or longer was associated with stricture resolution rates of 97 percent, with a stricture recurrence rate of 2 percent after mean follow-up ranging from 11 to 40 months [
         <a href="#rid49">
          49,59,70
         </a>
         ]. Most patients with stricture recurrence were successfully managed with endoscopic therapy with repeat plastic stenting. In a subsequent study including 56 patients with ABS, a course of endoscopic therapy with plastic stenting that required a median of four ERCPs was associated with a stricture resolution rate of 98 percent [
         <a href="#rid69">
          69
         </a>
         ]. ERCP-related adverse events occurred in 3 of 56 patients (5 percent). After a median follow-up of nearly six years after stent removal, 3 of 50 patients (6 percent) had recurrent ABS. All three patients were successfully treated with endoscopic therapy and were asymptomatic after further median follow-up of nearly six years.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Strategies to reduce the number of stent exchanges have included a multi-stenting technique with stent exchange for selected indications (eg, biliary obstruction). In a study of 83 patients with ABS who had ERCP with stenting, a maximum of nine plastic stents were placed during the index procedure [
         <a href="#rid70">
          70
         </a>
         ]. ERCP was repeated if biliary obstruction developed, if two or fewer stents remained, or if one year had passed without stent exchange. This approach was associated with a stricture resolution rate of 94 percent, while four patients (6 percent) required surgery (hepaticojejunostomy). After a median follow-up of 11 months, two patients (3 percent) required repeat ERCP for recurrent ABS.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3980551253">
         <span class="h4">
          Technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         The technique for stent placement is informed by stent type (see
         <a class="medical medical_review" href="/z/d/html/632.html" rel="external">
          "Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/640.html" rel="external">
          "Endoscopic biliary sphincterotomy"
         </a>
         ):
        </p>
        <p>
         For fully covered SEMS placement:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Place a guidewire across the stricture
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Place a covered SEMS across the biliary stricture
        </p>
        <p>
        </p>
        <p>
         After the index procedure, ERCP is repeated in approximately six months to remove the covered SEMS and assess the stricture. Stricture resolution is defined by absence of the stricture on fluoroscopy and no resistance with a balloon (8 to 10 mm) sweep from the proximal to the distal bile duct [
         <a href="#rid61">
          61
         </a>
         ]. If the stricture persists after stent removal, we place another fully covered SEMS across the stricture. After three to six months, we remove the covered SEMS endoscopically.
        </p>
        <p>
         For plastic stent placement:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Place a guidewire across the stricture
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Perform biliary sphincterotomy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dilate the stricture using balloons with diameters ranging from 6 to 8 mm
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Place one to three plastic stents (size range: 7 to 10 Fr) in a parallel fashion across the stricture
        </p>
        <p>
        </p>
        <p>
         After the index procedure, ERCP is repeated in approximately three months for the following interventions: the previously-placed stents are removed, the stricture is examined and dilated if needed, and new stents are replaced across the stricture if they are still warranted. An increasing number of stents are generally used at each subsequent endoscopic session to achieve stricture resolution.
        </p>
        <p class="headingAnchor" id="H4136730859">
         <span class="h3">
          Subsequent intervention
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who do not respond to ERCP-guided stenting or who have recurrent ABS after responding to an initial course of endoscopic therapy, subsequent options include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Repeat course of endoscopic therapy – Repeat endoscopic therapy with stent placement has been associated with long-term success. In a study of 24 patients with recurrent ABS related to liver transplantation, 20 patients (83 percent) had long-term resolution of the stricture following at least one additional course of endoscopic therapy [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Non-endoscopic interventions – Endoscopic therapy for ABS may be unsuccessful due to any of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with fibrotic and/or angulated ABS, the guidewire rarely cannot be placed across the stricture during ERCP, a step that is necessary prior to stent placement [
         <a href="#rid51">
          51,53,55,72,73
         </a>
         ]. Some patients require surgery for definitive therapy [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with Roux-en-Y choledochojejunostomy, ERCP may be unsuccessful, despite use of small bowel enteroscopy or other advanced endoscopic approaches. In such patients, percutaneous transhepatic cholangiography (PTC) and stricture dilation can be performed by interventional radiology, followed by placement of a percutaneous transhepatic catheter [
         <a href="#rid75">
          75
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15864.html" rel="external">
          "ERCP in patients with Roux-en-Y anatomy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Surgical revision may ultimately be required in patients with strictures that are refractory to endoscopic and/or percutaneous treatment. A Roux-en-Y choledochojejunostomy is usually performed in patients with duct-to-duct anastomosis. For patients who already have a Roux-en-Y anastomosis, repositioning the bile duct of the graft to a well-vascularized area may be required.
        </p>
        <p class="headingAnchor" id="H1703275496">
         <span class="h3">
          Monitoring after endoscopic therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         After stricture resolution, we monitor patients periodically with liver biochemistries (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and total bilirubin) (eg, every one to three months). If liver enzymes are elevated over baseline values, magnetic resonance cholangiography is obtained for further evaluation. Patients with ABS require long-term surveillance and clinical follow-up since strictures may recur. Based on clinical observation and experience, risk factors for recurrence include initial presentation &gt;6 months after LT and very tight strictures.
        </p>
        <p class="headingAnchor" id="H148028645">
         <span class="h2">
          Nonanastomotic strictures
         </span>
        </p>
        <p class="headingAnchor" id="H3521259017">
         <span class="h3">
          Incidence and etiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Non-anastomotic biliary strictures (NABS) account for 10 to 25 percent of all stricture-related adverse events after LT, with a reported incidence ranging from 0.5 to 10 percent [
         <a href="#rid22">
          22,24,29,50,76-78
         </a>
         ].
        </p>
        <p>
         NABS result mainly from hepatic artery thrombosis or other forms of ischemia. Less commonly, they can be due to recurrence of the underlying disease such as primary sclerosing cholangitis. Impaired blood supply may cause injury to the peribiliary glands and vascular plexus. Damage to these structures has been associated with the development of NABS after transplantation [
         <a href="#rid79">
          79
         </a>
         ]. NABS are more common when donor organs have been retrieved after cardiac death. (See
         <a class="medical medical_review" href="/z/d/html/4592.html" rel="external">
          "Liver transplantation in adults: Deceased donor evaluation and selection", section on 'Donation after circulatory death'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H219108014">
         <span class="h3">
          Clinical features
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Timing – NABS usually develop within three to six months after LT, although they can present up to one year following surgery [
         <a href="#rid50">
          50,77
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Location and appearance – NABS appear as an irregularity or narrowing of the lumen of the intra- or extrahepatic duct, and NABS have been defined as being located at least 1 cm proximal to the anastomosis [
         <a href="#rid47">
          47,80
         </a>
         ]. There may be multiple strictures involving the hilum of the liver and intrahepatic ducts, causing a cholangiographic appearance that resembles primary sclerosing cholangitis. Biliary sludge can accumulate proximal to the strictures, leading to the formation of casts [
         <a href="#rid81">
          81
         </a>
         ]. This may predispose the patient to develop recurrent episodes of cholangitis. (See
         <a class="local">
          'Bile duct casts'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1978951117">
         <span class="h3">
          Management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic therapy for extrahepatic NABS typically consists of ERCP and stricture dilation with a 4 to 6 mm balloon, followed by sphincterotomy and placement of plastic stents (size range: 10 to 11.5 Fr). Plastic stents are replaced every three months for approximately 6 to 12 months, and usually these strictures may require prolonged treatment including balloon dilatations and removals of casts and debris [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         NABS are often challenging to treat because they may be multiple, diffuse, and/or involve small intrahepatic ducts that may be difficult to reach endoscopically [
         <a href="#rid47">
          47
         </a>
         ]. Approximately 50 percent of patients have a long-term response to endoscopic therapy with stricture dilation and stent placement [
         <a href="#rid1">
          1,50,81-84
         </a>
         ]. Some patients may require other interventions for treating NABS such as PTC or surgical revision (eg, conversion of duct-to-duct anastomosis to hepaticojejunostomy). However, up to 50 percent of patients experience progressive disease despite endoscopic therapy, leading to retransplantation or death [
         <a href="#rid6">
          6,50,77,81
         </a>
         ]. Diffuse intrahepatic bile duct strictures have been associated with increased risk of poor graft survival and in many instances will require retransplantation for patients who are suitable candidates. (See
         <a class="medical medical_review" href="/z/d/html/4585.html" rel="external">
          "Liver transplantation in adults: Patient selection and pretransplantation evaluation"
         </a>
         .)
        </p>
        <p>
         As an example, in a study including 81 patients with NABS, 28 patients (35 percent) underwent interventional treatment (ERCP, PTC, or surgery) [
         <a href="#rid81">
          81
         </a>
         ]. Intervention was associated with improvement in liver enzymes; however, other outcomes were not reported for this subgroup of patients. Among 59 patients with NABS and radiologic follow up after a median of nearly two years, 28 patients (42 percent) had progressive biliary abnormalities on cholangiography [
         <a href="#rid81">
          81
         </a>
         ]. Cirrhosis or advanced fibrosis developed in 23 patients (28 percent). Although graft survival was compromised (73 percent at five years), patient survival was not affected. Thirteen patients (16 percent) underwent liver retransplantation.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          BILE LEAKS
         </span>
        </p>
        <p class="headingAnchor" id="H2271652855">
         <span class="h2">
          Incidence and etiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bile leaks may originate from the anastomosis, the cystic duct remnant, or from the cut surface of the liver (for recipients of a living donor liver)  (
         <a class="graphic graphic_diagnosticimage graphicRef82625" href="/z/d/graphic/82625.html" rel="external">
          image 3
         </a>
         ). Bile leaks are often related to technical issues such as lack of perfusion from the hepatic artery and tension at the anastomosis [
         <a href="#rid48">
          48
         </a>
         ]. In a systematic review of 61 studies, bile leak rates for recipients of deceased donor liver transplantation were 7.8 percent and for recipients of living donor liver transplantation (LDLT) were 9.5 percent [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
         Bile leak following liver transplant is a risk factor for developing biliary strictures and thus requires prompt intervention [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3904242753">
         <span class="h2">
          Clinical features and diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most bile leaks develop within four weeks after LT and usually occur at the anastomotic site. Bile leaks are suspected in patients with abdominal pain, peritonitis, and/or jaundice.
        </p>
        <p>
         The diagnosis of a bile leak can usually be confirmed with a transabdominal ultrasound that demonstrates a fluid collection. Magnetic resonance cholangiopancreatography (MRCP) can also detect a bile leak if transabdominal ultrasound is nondiagnostic. Hepatobiliary scintigraphy scanning, which has a sensitivity of approximately 50 percent and a specificity of approximately 80 percent, may also be useful for evaluating suspected bile leaks when other imaging studies are equivocal [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1973860551">
         <span class="h2">
          Management
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goal of endoscopic therapy is to eliminate the transpapillary pressure gradient, thereby permitting preferential transpapillary bile flow rather than extravasation at the site of the leak.
        </p>
        <p>
         Endoscopic management of bile leaks is informed by the type of biliary anastomosis and severity of the bile leak (eg, size of fluid collection):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with duct-to-duct anastomosis
         </strong>
         – For recipients with duct-to-duct anastomosis and bile leak, ERCP-guided placement of a plastic, transpapillary biliary stent, with or without biliary sphincterotomy is performed because this approach is effective for resolving most bile leaks [
         <a href="#rid1">
          1,87-89
         </a>
         ]. The duration of plastic stenting is approximately two months because of the potential risk of delayed healing related to immunosuppression [
         <a href="#rid6">
          6
         </a>
         ]. Stent exchange is required only if recurrent biliary obstruction is suspected (eg, jaundice, elevated liver enzymes). After six to eight weeks of stenting, most leaks have healed, and the stent is removed endoscopically.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For some patients with small or low-grade leaks (ie, a leak that requires near complete intrahepatic filling to demonstrate contrast extravasation), some advanced endoscopists perform ERCP with biliary sphincterotomy alone rather than ERCP with stent placement. However, published data supporting this approach are lacking. In a study including 80 patients with bile leaks, ERCP with plastic stent placement (with or without sphincterotomy) was associated with higher rates of bile leak resolution compared with sphincterotomy alone (94 versus 58 percent) [
         <a href="#rid90">
          90
         </a>
         ]. Endoscopic approaches to managing bile leaks in the nontransplant setting are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/637.html" rel="external">
          "Endoscopic management of postcholecystectomy biliary complications", section on 'Bile leak'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Endoscopic therapy has been effective for managing bile leaks related to LT [
         <a href="#rid1">
          1,6,49,87,88,90
         </a>
         ]. In a systematic review of 34 studies including 370 LT recipients with bile leak who were treated with endoscopic biliary stent placement, 278 patients (82 percent) had complete resolution of the bile leak [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with Roux-en-Y anatomy
         </strong>
         – For recipients with Roux-en-Y hepaticojejunostomy, anastomotic bile leaks are less common. However, for such patients with a bile leak, ERCP is often not feasible due to anatomic difficulties in reaching the biliary anastomosis. Management usually involves percutaneous internal to external drainage. Bile leaks in patients with Roux-en-Y anatomy may require surgical management if less invasive methods for diverting bile flow are not successful. (See
         <a class="medical medical_review" href="/z/d/html/15864.html" rel="external">
          "ERCP in patients with Roux-en-Y anatomy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with a T-tube
         </strong>
         – For patients undergoing LT, most centers no longer use T-tubes (ie, a T-shaped draining tube that is inserted into the common bile duct and exits through the abdominal wall to the skin surface in the right upper quadrant). (See
         <a class="medical medical_review" href="/z/d/html/15093.html" rel="external">
          "Surgical common bile duct exploration", section on 'T-tube placement'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, for recipients with a T-tube, small anastomotic leaks can be diagnosed with a T-tube cholangiogram and managed by leaving the tube open to drainage without further intervention.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Following removal of a T-tube, some patients will develop a bile leak that results from delay in T-tube tract maturation due to immunosuppression. A bile leak should be suspected in patients who develop abdominal pain when the T-tube is removed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         ERCP (with or without sphincterotomy) with placement of biliary stent may be indicated for such patients, particularly in patients with abdominal pain. An alternative approach consisting of medical management with analgesics and observation for up to one week is also reasonable. If symptoms persist, management with ERCP and placement of transpapillary biliary stents is indicated [
         <a href="#rid1">
          1,6,29,49,91
         </a>
         ]. Surgery or a percutaneous transhepatic approach is reserved for patients in whom ERCP is unsuccessful.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          BILE DUCT FILLING DEFECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Filling defects in the bile duct after LT can be due to stones, sludge, blood clots, casts, and/or migrated stents; most defects are caused by stones [
         <a href="#rid1">
          1
         </a>
         ]. Reported rates of bile duct filling defects have ranged from 2 to 10 percent [
         <a href="#rid24">
          24,49,89,92
         </a>
         ]. The potential mechanisms related to the formation of stones, sludge, and casts include bile duct stricture and/or obstruction, prolonged warm and cold ischemia times, and bacterial infection [
         <a href="#rid6">
          6,25,93,94
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Bile duct stones
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stones usually develop late (&gt;1 year) after LT  (
         <a class="graphic graphic_diagnosticimage graphicRef66728" href="/z/d/graphic/66728.html" rel="external">
          image 4
         </a>
         ). As an example, in one series of 37 LT recipients with biliary stones, bile duct stones were identified at a median of 19 months after LT [
         <a href="#rid49">
          49
         </a>
         ]. Following ERCP with stone extraction, the stone recurrence rate was 17 percent after median of six months. For most patients with biliary stones, one ERCP session with biliary sphincterotomy is effective for clearing the bile duct; however, for some patients, two or more endoscopic sessions may be required [
         <a href="#rid49">
          49,92
         </a>
         ].
        </p>
        <p>
         Endoscopic management of bile duct stones and sludge is similar to the nontransplant setting, and is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13922.html" rel="external">
          "Choledocholithiasis: Clinical manifestations, diagnosis, and management", section on 'Subsequent evaluation and management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/674.html" rel="external">
          "Endoscopic management of bile duct stones"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Bile duct casts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bile duct casts are usually related to ischemic injury (eg, hepatic artery thrombosis) or diffuse stricture formation in the hilum of the liver graft [
         <a href="#rid95">
          95
         </a>
         ]. Clearance of casts may be difficult to achieve with endoscopic methods. In one series, combined endoscopic and percutaneous methods were able to successfully clear the casts in 60 percent of patients [
         <a href="#rid95">
          95
         </a>
         ]. Various combinations of endoscopic methods including sphincterotomy, balloon and basket extraction, stent placement, and lithotripsy are often necessary, and many patients will ultimately require management with percutaneous intervention.
        </p>
        <p>
         Patients with Roux-en-Y choledochojejunostomy and bile duct stones are typically managed with percutaneous drainage.
        </p>
        <p>
         Biliary cast syndrome is an uncommon adverse event of LT that is characterized by biliary casts and debris causing biliary obstruction and cholangitis after LT. In two case series including a total of 1242 LT recipients, reported rates of biliary cast syndrome were 3 percent [
         <a href="#rid96">
          96,97
         </a>
         ]. The etiology of biliary cast syndrome is not well understood. Associated risk factors include hepatic artery stenosis and biliary strictures. Biliary cast syndrome has been associated with limited graft survival. Several endoscopic interventions have been described with variable success, and some patients have undergone retransplantation [
         <a href="#rid96">
          96
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          OTHER ADVERSE EVENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other adverse events of liver transplantation that involve the biliary tree include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Biloma – In patients with bile duct necrosis secondary to hepatic artery thrombosis, bilomas can occur due to bile duct perforation and extravasation of bile into the hepatic parenchyma or the abdominal cavity. Most bilomas occur in the perihepatic area, outside of the liver. If the biloma occurs in the hepatic parenchyma and communicates with the biliary tree, it may resolve spontaneously or, in some cases, may be managed with endoscopy and transpapillary stent placement. However, in this setting, the role of endoscopy is more diagnostic than therapeutic, as disrupted bile ducts may not completely communicate with the extrahepatic ducts.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Large bilomas not communicating with the extrahepatic bile ducts are managed with percutaneous drainage and antibiotics. Surgery is indicated when the bile leak cannot be effectively controlled with nonsurgical methods. (See
         <a class="medical medical_review" href="/z/d/html/3682.html" rel="external">
          "Repair of common bile duct injuries"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sphincter of Oddi disorder – Sphincter of Oddi disorder (SOD) has been described in 1 to 7 percent of LT recipients [
         <a href="#rid22">
          22,49,87,98,99
         </a>
         ]. The pathogenesis is unclear; one hypothesis is that denervation of the common bile duct in the ampullary region (secondary to surgical intervention) leads to the development of a hypertonic sphincter, causing dilated ducts and cholestasis [
         <a href="#rid7">
          7,93
         </a>
         ]. Data have suggested that papillary stenosis and functional biliary sphincter disorders (as defined by Rome IV criteria) are uncommon and occur in 1 percent in LT recipients [
         <a href="#rid100">
          100,101
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         SOD is suspected in patients with cholestasis and a uniformly dilated bile duct without filling defects; abdominal pain is not usually present. In most studies, the diagnosis of SOD was based upon clinical suspicion and the response to biliary sphincterotomy. Other causes of cholestasis or elevated liver enzymes (eg, acute T-cell mediated rejection) should be excluded. (See
         <a class="medical medical_review" href="/z/d/html/4587.html" rel="external">
          "Liver transplantation in adults: Clinical manifestations and diagnosis of acute T-cell mediated (cellular) rejection of the liver allograft", section on 'Diagnostic evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Management of SOD in LT recipients is similar to the nontransplant setting (ie, biliary sphincterotomy), and this is discussed separately [
         <a href="#rid101">
          101
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          SPECIAL POPULATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H4243276462">
         <span class="h2">
          Recipients of living donor liver transplantation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Biliary adverse events after living donor liver transplantation (LDLT) may be related to surgical factors (multiple and/or small caliber ducts used for anastomosis, type of reconstruction) and non-surgical factors (older donor age) [
         <a href="#rid102">
          102-106
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4590.html" rel="external">
          "Living donor liver transplantation in adults", section on 'Recipient outcomes'
         </a>
         .)
        </p>
        <p>
         For LDLT, many transplantation centers perform duct-to-duct anastomosis rather than Roux-en-Y choledochojejunostomy because duct-to-duct anastomosis has the potential advantage of a shorter operation time, no contamination by bowel contents, and a preserved sphincter of Oddi [
         <a href="#rid20">
          20
         </a>
         ]. However, data have suggested that the risk of biliary stricture was lower with Roux-en-Y anatomy. In a meta-analysis of six studies including 1286 recipients of LDLT, 260 patients (20 percent) developed anastomotic biliary stricture and 118 patients (9 percent) had bile leak. Roux-en-Y choledochojejunostomy was associated with a lower risk of anastomotic biliary stricture (ABS) compared with duct-to-duct anastomosis (odds ratio 0.45, 95% CI 0.31–0.64) [
         <a href="#rid107">
          107
         </a>
         ]. Rates of bile leak were not significantly different between groups.
        </p>
        <p>
         Management of biliary strictures in recipients of living donor livers is similar to recipients of deceased donor livers and typically consists of ERC with balloon dilation and plastic stent placement for patients with duct-to-duct anastomosis. Reported rates of stricture resolution with this approach have ranged from 50 to 79 percent [
         <a href="#rid58">
          58,108-110
         </a>
         ]. For patients who do not respond to endoscopic therapy or for those with Roux-en-Y anatomy, percutaneous transhepatic biliary drainage with stricture dilation is an alternative option [
         <a href="#rid111">
          111
         </a>
         ]. As an example, in a study of 110 patients with LDLT and duct-to-duct anastomosis, 38 patients (35 percent) developed an anastomotic stricture, and ERCP was attempted as initial therapy in all patients [
         <a href="#rid58">
          58
         </a>
         ]. Thirty-two patients (84 percent) were managed with endoscopic therapy alone, while six patients required a combination of percutaneous transhepatic cholangiography initially to cross the stricture, followed by endoscopic therapy. A median of four endoscopic sessions were required for stricture resolution. For most patients, strictures remained patent during an average follow up of 70 months, while eight patients (21 percent) had recurrent stricture after initial treatment success. All patients with stricture recurrence were successfully retreated with endoscopic therapy. (See
         <a class="local">
          'Biliary strictures'
         </a>
         above.)
        </p>
        <p>
         Use of fully covered SEMS has been reported as an alternative for managing biliary adverse events in LDLT recipients. In a small cohort of 13 LDLT recipients with biliary strictures with median follow-up of 15 months, covered SEMS placement was associated with stricture resolution rate of 92 percent [
         <a href="#rid112">
          112
         </a>
         ]. Although preliminary studies suggested that use of fully covered SEMS was safe in LDLT recipients, long-term data are lacking [
         <a href="#rid113">
          113,114
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H363328983">
         <span class="h2">
          Living liver donors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Living liver donors may experience biliary adverse events following donor hepatectomy. Data from the Adult-to-Adult Living Donor Liver Transplantation Cohort consortium on liver donor outcomes included two studies with total of 1133 liver donors. The reported rate for overall biliary adverse events was 10 percent and for bile leak was 9 percent [
         <a href="#rid115">
          115-117
         </a>
         ]. Biliary adverse events in liver donors are seen more often with right lobe donation than with left lobe donation, and the management is similar to that described for liver transplantation recipients. (See
         <a class="medical medical_review" href="/z/d/html/4590.html" rel="external">
          "Living donor liver transplantation in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          ENDOSCOPY-RELATED ADVERSE EVENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risks of advanced endoscopic interventions are generally regarded as similar for LT transplant recipients and nontransplant patients. For LT recipients, the estimated overall adverse event rates of up to 9 percent have been reported [
         <a href="#rid1">
          1,118
         </a>
         ]. The most common adverse events are pancreatitis, cholangitis, and sphincterotomy-related bleeding. Adverse events of endoscopic retrograde cholangiopancreatography are discussed in more detail separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/629.html" rel="external">
          "Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/641.html" rel="external">
          "Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/636.html" rel="external">
          "Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H81649680">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113977.html" rel="external">
          "Society guideline links: Liver transplantation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence and risk factors
         </strong>
         – The estimated incidence of biliary adverse events related to LT ranges from 10 to 15 percent in recipients of deceased donor livers and from 15 to 30 percent in recipients of living donor livers. Risk factors for biliary adverse events are listed in the table  (
         <a class="graphic graphic_table graphicRef50456" href="/z/d/graphic/50456.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Incidence and risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – Biliary adverse events after LT are suspected in recipients with elevations in liver enzymes, primarily in a cholestatic pattern (ie, disproportionate elevation of alkaline phosphatase compared with aminotransferases) with or without symptoms (eg, fever, right upper quadrant abdominal pain, jaundice). For such patients, the evaluation begins with a transabdominal liver ultrasound with a Doppler study, and further testing is informed by ultrasound findings. (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For patients with suspected biliary obstruction, the approach to care is outlined in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef56381" href="/z/d/graphic/56381.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anastomotic biliary strictures
         </strong>
         – For most patients with anastomotic biliary stricture (ABS) and duct-to-duct anastomosis, we suggest ERCP-guided intervention rather than percutaneous transhepatic cholangiography (PTC)-guided intervention or surgery (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). An ERCP-guided approach with stent placement has been associated with long-term stricture resolution. (See
         <a class="local">
          'Biliary strictures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         PTC is reserved for patients in whom ERCP is unsuccessful or for some patients with Roux-en-Y choledochojejunostomy. (See
         <a class="medical medical_review" href="/z/d/html/15864.html" rel="external">
          "ERCP in patients with Roux-en-Y anatomy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For patients with a fully covered, self-expandable metal stent (SEMS), we typically remove the stent endoscopically in six months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For patients with plastic stent(s), we perform stent exchange approximately every three months for a total stent indwelling time of 6 to 12 months. Most patients with plastic stenting will require a total of three to five endoscopic sessions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         After stricture resolution, we monitor patients with liver enzymes every one to three months and obtain imaging (eg, magnetic resonance cholangiogram [MRC]) when there is a rise in liver enzymes over baseline values.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Non-anastomotic biliary strictures
         </strong>
         – For most patients with non-anastomotic biliary strictures (NABS) for which endoscopic therapy would be feasible, we suggest ERCP-guided balloon dilatation and plastic stent placement rather than PTC-guided or surgical intervention (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). However, NABS are challenging to treat endoscopically, and some patients will require PTC-guided intervention, surgical revision, or retransplantation if progressive disease with diffuse biliary stricturing develops. (See
         <a class="local">
          'Nonanastomotic strictures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bile leak
         </strong>
         – For most patients with duct-to-duct anastomosis complicated by a bile leak after LT, we suggest ERCP-guided intervention rather than PTC-guided intervention or surgery (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). An ERCP-guided approach has been effective for resolving bile leaks.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We perform ERCP with placement of a transpapillary plastic stent, with or without biliary sphincterotomy. Stents generally remain in place for approximately two months to allow for healing of the ductal defect. ERCP is then repeated to confirm that the bile leak has resolved and to remove the stents. (See
         <a class="local">
          'Bile leaks'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Endoscopy-related adverse events
         </strong>
         – The risks of endoscopy-related adverse events for LT recipients are similar to those reported for patients in the nontransplant setting. The most common adverse events are pancreatitis, cholangitis, and sphincterotomy-related bleeding:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/629.html" rel="external">
          "Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/641.html" rel="external">
          "Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/636.html" rel="external">
          "Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding"
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Thuluvath PJ, Atassi T, Lee J. An endoscopic approach to biliary complications following orthotopic liver transplantation. Liver Int 2003; 23:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seehofer D, Eurich D, Veltzke-Schlieker W, Neuhaus P. Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant 2013; 13:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roos FJM, Poley JW, Polak WG, Metselaar HJ. Biliary complications after liver transplantation; recent developments in etiology, diagnosis and endoscopic treatment. Best Pract Res Clin Gastroenterol 2017; 31:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee HW, Shah NH, Lee SK. An Update on Endoscopic Management of Post-Liver Transplant Biliary Complications. Clin Endosc 2017; 50:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fasullo M, Patel M, Khanna L, Shah T. Post-transplant biliary complications: advances in pathophysiology, diagnosis, and treatment. BMJ Open Gastroenterol 2022; 9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thuluvath PJ, Pfau PR, Kimmey MB, Ginsberg GG. Biliary complications after liver transplantation: the role of endoscopy. Endoscopy 2005; 37:857.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pascher A, Neuhaus P. Biliary complications after deceased-donor orthotopic liver transplantation. J Hepatobiliary Pancreat Surg 2006; 13:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graziadei IW. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2002; 8:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maheshwari A, Maley W, Li Z, Thuluvath PJ. Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl 2007; 13:1645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma S, Gurakar A, Jabbour N. Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl 2008; 14:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fung JJ, Eghtesad B, Patel-Tom K. Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel. Liver Transpl 2007; 13:1633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Welling TH, Heidt DG, Englesbe MJ, et al. Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl 2008; 14:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dacha S, Barad A, Martin J, Levitsky J. Association of hepatic artery stenosis and biliary strictures in liver transplant recipients. Liver Transpl 2011; 17:849.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg 2011; 253:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sundaram V, Jones DT, Shah NH, et al. Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era. Liver Transpl 2011; 17:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brunner SM, Junger H, Ruemmele P, et al. Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation. J Hepatol 2013; 58:1133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baccarani U, Isola M, Adani GL, et al. Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications. Clin Transplant 2010; 24:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larghi A, Tringali A, Rimbaş M, et al. Endoscopic Management of Benign Biliary Strictures After Liver Transplantation. Liver Transpl 2019; 25:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wan P, Yu X, Xia Q. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis. Liver Transpl 2014; 20:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang SF, Huang ZY, Chen XP. Biliary complications after living donor liver transplantation. Liver Transpl 2011; 17:1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zimmerman MA, Baker T, Goodrich NP, et al. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Liver Transpl 2013; 19:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greif F, Bronsther OL, Van Thiel DH, et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994; 219:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davidson BR, Rai R, Kurzawinski TR, et al. Prospective randomized trial of end-to-end versus side-to-side biliary reconstruction after orthotopic liver transplantation. Br J Surg 1999; 86:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park JS, Kim MH, Lee SK, et al. Efficacy of endoscopic and percutaneous treatments for biliary complications after cadaveric and living donor liver transplantation. Gastrointest Endosc 2003; 57:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verdonk RC, Buis CI, Porte RJ, Haagsma EB. Biliary complications after liver transplantation: a review. Scand J Gastroenterol Suppl 2006; :89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scatton O, Meunier B, Cherqui D, et al. Randomized trial of choledochocholedochostomy with or without a T tube in orthotopic liver transplantation. Ann Surg 2001; 233:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amador A, Charco R, Marti J, et al. Cost/efficacy clinical trial about the use of T-tube in cadaveric donor liver transplant: preliminary results. Transplant Proc 2005; 37:1129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sotiropoulos GC, Sgourakis G, Radtke A, et al. Orthotopic liver transplantation: T-tube or not T-tube? Systematic review and meta-analysis of results. Transplantation 2009; 87:1672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thethy S, Thomson BNj, Pleass H, et al. Management of biliary tract complications after orthotopic liver transplantation. Clin Transplant 2004; 18:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krok KL, Cárdenas A, Thuluvath PJ. Endoscopic management of biliary complications after liver transplantation. Clin Liver Dis 2010; 14:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amateau SK, Kohli DR, Desai M, et al. American Society for Gastrointestinal Endoscopy guideline on management of post-liver transplant biliary strictures: methodology and review of evidence. Gastrointest Endosc 2023; 97:615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chahal P, Baron TH, Poterucha JJ, Rosen CB. Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with Roux-en-Y biliary reconstruction. Liver Transpl 2007; 13:1168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawano Y, Mizuta K, Hishikawa S, et al. Rendezvous penetration method using double-balloon endoscopy for complete anastomosis obstruction of hepaticojejunostomy after pediatric living donor liver transplantation. Liver Transpl 2008; 14:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chua TJ, Kaffes AJ. Balloon-assisted enteroscopy in patients with surgically altered anatomy: a liver transplant center experience (with video). Gastrointest Endosc 2012; 76:887.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abbasoglu O, Levy MF, Vodapally MS, et al. Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome. Transplantation 1997; 63:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frongillo F, Grossi U, Lirosi MC, et al. Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match. Transplant Proc 2013; 45:2722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldsmith LE, Wiebke K, Seal J, et al. Complications after endovascular treatment of hepatic artery stenosis after liver transplantation. J Vasc Surg 2017; 66:1488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Potthoff A, Hahn A, Kubicka S, et al. Diagnostic value of ultrasound in detection of biliary tract complications after liver transplantation. Hepat Mon 2013; 13:e6003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atwal T, Pastrana M, Sandhu B. Post-liver Transplant Biliary Complications. J Clin Exp Hepatol 2012; 2:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jorgensen JE, Waljee AK, Volk ML, et al. Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis. Gastrointest Endosc 2011; 73:955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elmunzer BJ, Debenedet AT, Volk ML, et al. Clinical yield of diagnostic endoscopic retrograde cholangiopancreatography in orthotopic liver transplant recipients with suspected biliary complications. Liver Transpl 2012; 18:1479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kohli DR, Amateau SK, Desai M, et al. American Society for Gastrointestinal Endoscopy guideline on management of post-liver transplant biliary strictures: summary and recommendations. Gastrointest Endosc 2023; 97:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paymani M, Zajko AB, Campbell WL. Bile leakage as a complication of liver biopsy in liver transplants. Abdom Imaging 1993; 18:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akamatsu N, Sugawara Y, Hashimoto D. Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome. Transpl Int 2011; 24:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rammohan A, Govil S, Vargese J, et al. Changing pattern of biliary complications in an evolving liver transplant unit. Liver Transpl 2017; 23:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albert JG, Filmann N, Elsner J, et al. Long-term follow-up of endoscopic therapy for stenosis of the biliobiliary anastomosis associated with orthotopic liver transplantation. Liver Transpl 2013; 19:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Magro B, Tacelli M, Mazzola A, et al. Biliary complications after liver transplantation: current perspectives and future strategies. Hepatobiliary Surg Nutr 2021; 10:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boeva I, Karagyozov PI, Tishkov I. Post-liver transplant biliary complications: Current knowledge and therapeutic advances. World J Hepatol 2021; 13:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rerknimitr R, Sherman S, Fogel EL, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc 2002; 55:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graziadei IW, Schwaighofer H, Koch R, et al. Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl 2006; 12:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verdonk RC, Buis CI, Porte RJ, et al. Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl 2006; 12:726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zoepf T, Maldonado-Lopez EJ, Hilgard P, et al. Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation. Liver Transpl 2006; 12:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morelli J, Mulcahy HE, Willner IR, et al. Long-term outcomes for patients with post-liver transplant anastomotic biliary strictures treated by endoscopic stent placement. Gastrointest Endosc 2003; 58:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pasha SF, Harrison ME, Das A, et al. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc 2007; 66:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holt AP, Thorburn D, Mirza D, et al. A prospective study of standardized nonsurgical therapy in the management of biliary anastomotic strictures complicating liver transplantation. Transplantation 2007; 84:857.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kulaksiz H, Weiss KH, Gotthardt D, et al. Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy 2008; 40:746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seo JK, Ryu JK, Lee SH, et al. Endoscopic treatment for biliary stricture after adult living donor liver transplantation. Liver Transpl 2009; 15:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsieh TH, Mekeel KL, Crowell MD, et al. Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc 2013; 77:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kao D, Zepeda-Gomez S, Tandon P, Bain VG. Managing the post-liver transplantation anastomotic biliary stricture: multiple plastic versus metal stents: a systematic review. Gastrointest Endosc 2013; 77:679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Costamagna G, Tringali A, Mutignani M, et al. Endotherapy of postoperative biliary strictures with multiple stents: results after more than 10 years of follow-up. Gastrointest Endosc 2010; 72:551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-Simon A, Díaz-Gonzalez A, Thuluvath PJ, Cárdenas A. Endoscopic retrograde cholangiography for biliary anastomotic strictures after liver transplantation. Clin Liver Dis 2014; 18:913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poley JW, Lekkerkerker MN, Metselaar HJ, et al. Clinical outcome of progressive stenting in patients with anastomotic strictures after orthotopic liver transplantation. Endoscopy 2013; 45:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaffes A, Griffin S, Vaughan R, et al. A randomized trial of a fully covered self-expandable metallic stent versus plastic stents in anastomotic biliary strictures after liver transplantation. Therap Adv Gastroenterol 2014; 7:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coté GA, Slivka A, Tarnasky P, et al. Effect of Covered Metallic Stents Compared With Plastic Stents on Benign Biliary Stricture Resolution: A Randomized Clinical Trial. JAMA 2016; 315:1250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tal AO, Finkelmeier F, Filmann N, et al. Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation: a prospective, randomized, multicenter trial. Gastrointest Endosc 2017; 86:1038.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martins FP, De Paulo GA, Contini MLC, Ferrari AP. Metal versus plastic stents for anastomotic biliary strictures after liver transplantation: a randomized controlled trial. Gastrointest Endosc 2018; 87:131.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Visconti TAC, Bernardo WM, Moura DTH, et al. Metallic vs plastic stents to treat biliary stricture after liver transplantation: a systematic review and meta-analysis based on randomized trials. Endosc Int Open 2018; 6:E914.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poley JW, Ponchon T, Puespoek A, et al. Fully covered self-expanding metal stents for benign biliary stricture after orthotopic liver transplant: 5-year outcomes. Gastrointest Endosc 2020; 92:1216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tringali A, Barbaro F, Pizzicannella M, et al. Endoscopic management with multiple plastic stents of anastomotic biliary stricture following liver transplantation: long-term results. Endoscopy 2016; 48:546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tabibian JH, Asham EH, Han S, et al. Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc 2010; 71:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dai SC, Goldberg D, Agarwal A, et al. Endoscopic Therapy is Effective for Recurrent Anastomotic Biliary Strictures after Orthotopic Liver Transplantation. Ann Hepatol 2017; 16:924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barriga J, Thompson R, Shokouh-Amiri H, et al. Biliary strictures after liver transplantation. Predictive factors for response to endoscopic management and long-term outcome. Am J Med Sci 2008; 335:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber A, Prinz C, Gerngross C, et al. Long-term outcome of endoscopic and/or percutaneous transhepatic therapy in patients with biliary stricture after orthotopic liver transplantation. J Gastroenterol 2009; 44:1195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balderramo D, Sendino O, Burrel M, et al. Risk factors and outcomes of failed endoscopic retrograde cholangiopancreatography in liver transplant recipients with anastomotic biliary strictures: a case-control study. Liver Transpl 2012; 18:482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piardi T, Greget M, Audet M, et al. Biliary strictures after liver transplantation: is percutaneous treatment indicated? Ann Transplant 2011; 16:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koneru B, Sterling MJ, Bahramipour PF. Bile duct strictures after liver transplantation: a changing landscape of the Achilles' heel. Liver Transpl 2006; 12:702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guichelaar MM, Benson JT, Malinchoc M, et al. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant 2003; 3:885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rizk RS, McVicar JP, Emond MJ, et al. Endoscopic management of biliary strictures in liver transplant recipients: effect on patient and graft survival. Gastrointest Endosc 1998; 47:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           op den Dries S, Westerkamp AC, Karimian N, et al. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. J Hepatol 2014; 60:1172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Rijn R, Schurink IJ, de Vries Y, et al. Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial. N Engl J Med 2021; 384:1391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verdonk RC, Buis CI, van der Jagt EJ, et al. Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl 2007; 13:725.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsujino T, Isayama H, Sugawara Y, et al. Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol 2006; 101:2230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tabibian JH, Asham EH, Goldstein L, et al. Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc 2009; 69:1236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buxbaum JL, Biggins SW, Bagatelos KC, Ostroff JW. Predictors of endoscopic treatment outcomes in the management of biliary problems after liver transplantation at a high-volume academic center. Gastrointest Endosc 2011; 73:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kochhar G, Parungao JM, Hanouneh IA, Parsi MA. Biliary complications following liver transplantation. World J Gastroenterol 2013; 19:2841.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanazawa A, Kubo S, Tanaka H, et al. Bile leakage after living donor liver transplantation demonstrated with hepatobiliary scan using 9mTc-PMT. Ann Nucl Med 2003; 17:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pfau PR, Kochman ML, Lewis JD, et al. Endoscopic management of postoperative biliary complications in orthotopic liver transplantation. Gastrointest Endosc 2000; 52:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raza A, Omer A, Iqbal S, et al. Efficacy of Nasobiliary Tubes and Biliary Stents in Management of Patients with Bile Leak after Liver Transplantation: A Systematic Review. Clin Endosc 2019; 52:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           López Álvarez M, Otero A, Vázquez Millán MA, et al. Endoscopic treatment of biliary complications after liver transplantation. Rev Esp Enferm Dig 2020; 112:605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sendino O, Fernández-Simon A, Law R, et al. Endoscopic management of bile leaks after liver transplantation: An analysis of two high-volume transplant centers. United European Gastroenterol J 2018; 6:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saab S, Martin P, Soliman GY, et al. Endoscopic management of biliary leaks after T-tube removal in liver transplant recipients: nasobiliary drainage versus biliary stenting. Liver Transpl 2000; 6:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spier BJ, Pfau PR, Lorenze KR, et al. Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study. Liver Transpl 2008; 14:1461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scanga AE, Kowdley KV. Management of biliary complications following orthotopic liver transplantation. Curr Gastroenterol Rep 2007; 9:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cillo U, Burra P, Norberto L, D'Amico D. Bile duct stones and casts after liver transplantation: Different entities but similar prevention strategy? Liver Transpl 2008; 14:1400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah JN, Haigh WG, Lee SP, et al. Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am J Gastroenterol 2003; 98:1861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gor NV, Levy RM, Ahn J, et al. Biliary cast syndrome following liver transplantation: Predictive factors and clinical outcomes. Liver Transpl 2008; 14:1466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voigtländer T, Negm AA, Strassburg CP, et al. Biliary cast syndrome post-liver transplantation: risk factors and outcome. Liver Int 2013; 33:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez-Simon A, Royg D, Sendino O, et al. Sphincter of Oddi Dysfunction after Liver Transplantation: Experience in a High Volume Transplant Center. Hepatology 2014; 60:545A.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarhan MD, Osman AMA, Mohamed MA, et al. Biliary Complications in Recipients of Living-Donor Liver Transplant: A Single-Center Review of 120 Patients. Exp Clin Transplant 2017; 15:648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cotton PB, Elta GH, Carter CR, et al. Rome IV. Gallbladder and Sphincter of Oddi Disorders. Gastroenterology 2016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez-Simon A, Sendino O, Chavez-Rivera K, et al. The presence and outcome of biliary sphincter disorders in liver-transplant recipients according to the Rome IV classification. Gastroenterol Rep (Oxf) 2021; 9:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tashiro H, Itamoto T, Sasaki T, et al. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment. World J Surg 2007; 31:2222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin TS, Concejero AM, Chen CL, et al. Routine microsurgical biliary reconstruction decreases early anastomotic complications in living donor liver transplantation. Liver Transpl 2009; 15:1766.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung DH, Ikegami T, Balci D, Bhangui P. Biliary reconstruction and complications in living donor liver transplantation. Int J Surg 2020; 82S:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah SA, Grant DR, McGilvray ID, et al. Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center. Am J Transplant 2007; 7:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chok KS, Chan SC, Cheung TT, et al. Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation. Liver Transpl 2011; 17:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chok KS, Lo CM. Systematic review and meta-analysis of studies of biliary reconstruction in adult living donor liver transplantation. ANZ J Surg 2017; 87:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yazumi S, Yoshimoto T, Hisatsune H, et al. Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis. J Hepatobiliary Pancreat Surg 2006; 13:502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chok KS, Chan SC, Cheung TT, et al. A retrospective study on risk factors associated with failed endoscopic treatment of biliary anastomotic stricture after right-lobe living donor liver transplantation with duct-to-duct anastomosis. Ann Surg 2014; 259:767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sato T, Kogure H, Nakai Y, et al. Long-term outcomes of endoscopic treatment for duct-to-duct anastomotic strictures after living donor liver transplantation. Liver Int 2019; 39:1954.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim ES, Lee BJ, Won JY, et al. Percutaneous transhepatic biliary drainage may serve as a successful rescue procedure in failed cases of endoscopic therapy for a post-living donor liver transplantation biliary stricture. Gastrointest Endosc 2009; 69:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sato T, Kogure H, Nakai Y, et al. A prospective study of fully covered metal stents for different types of refractory benign biliary strictures. Endoscopy 2020; 52:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoo JJ, Lee JK, Moon JH, et al. Intraductal placement of non-flared fully covered metallic stent for refractory anastomotic biliary strictures after living donor liver transplantation: Long-term results of prospective multicenter trial. J Gastroenterol Hepatol 2020; 35:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Komatsu N, Ozawa E, Fukushima M, et al. Fully covered metallic stents for anastomotic biliary strictures after living donor liver transplantation. DEN Open 2023; 3:e225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghobrial RM, Freise CE, Trotter JF, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008; 135:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abu-Gazala S, Olthoff KM. Status of Adult Living Donor Liver Transplantation in the United States: Results from the Adult-To-Adult Living Donor Liver Transplantation Cohort Study. Gastroenterol Clin North Am 2018; 47:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abecassis MM, Fisher RA, Olthoff KM, et al. Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant 2012; 12:1208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balderramo D, Bordas JM, Sendino O, et al. Complications after ERCP in liver transplant recipients. Gastrointest Endosc 2011; 74:285.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 4596 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12955878" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : An endoscopic approach to biliary complications following orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23331505" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Biliary complications after liver transplantation: old problems and new challenges.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28624111" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Biliary complications after liver transplantation; recent developments in etiology, diagnosis and endoscopic treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28415168" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : An Update on Endoscopic Management of Post-Liver Transplant Biliary Complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35552193" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Post-transplant biliary complications: advances in pathophysiology, diagnosis, and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16116539" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Biliary complications after liver transplantation: the role of endoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17139421" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Biliary complications after deceased-donor orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12089708" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Recurrence of primary sclerosing cholangitis after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18044778" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Biliary complications and outcomes of liver transplantation from donors after cardiac death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18508368" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Biliary strictures following liver transplantation: past, present and preventive strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18044764" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18161843" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21455929" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Association of hepatic artery stenosis and biliary strictures in liver transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21245668" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21445926" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23321317" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19878512" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30329213" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Endoscopic Management of Benign Biliary Strictures After Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24478109" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21761548" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Biliary complications after living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23495079" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8297175" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10215812" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Prospective randomized trial of end-to-end versus side-to-side biliary reconstruction after orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12518136" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Efficacy of endoscopic and percutaneous treatments for biliary complications after cadaveric and living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16782628" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Biliary complications after liver transplantation: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11224633" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Randomized trial of choledochocholedochostomy with or without a T tube in orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15848645" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cost/efficacy clinical trial about the use of T-tube in cadaveric donor liver transplant: preliminary results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19502959" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Orthotopic liver transplantation: T-tube or not T-tube? Systematic review and meta-analysis of results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15516238" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Management of biliary tract complications after orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20682241" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Endoscopic management of biliary complications after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36792483" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : American Society for Gastrointestinal Endoscopy guideline on management of post-liver transplant biliary strictures: methodology and review of evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17663414" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with Roux-en-Y biliary reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18306384" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Rendezvous penetration method using double-balloon endoscopy for complete anastomosis obstruction of hepaticojejunostomy after pediatric living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22840290" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Balloon-assisted enteroscopy in patients with surgically altered anatomy: a liver transplant center experience (with video).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9020326" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24034032" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28697937" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Complications after endovascular treatment of hepatic artery stenosis after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23483295" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Diagnostic value of ultrasound in detection of biliary tract complications after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25755409" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Post-liver Transplant Biliary Complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21316670" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22888069" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Clinical yield of diagnostic endoscopic retrograde cholangiopancreatography in orthotopic liver transplant recipients with suspected biliary complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36797162" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : American Society for Gastrointestinal Endoscopy guideline on management of post-liver transplant biliary strictures: summary and recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8508087" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Bile leakage as a complication of liver biopsy in liver transplants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21143651" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28152569" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Changing pattern of biliary complications in an evolving liver transplant unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23585381" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Long-term follow-up of endoscopic therapy for stenosis of the biliobiliary anastomosis associated with orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33575291" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Biliary complications after liver transplantation: current perspectives and future strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33584987" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Post-liver transplant biliary complications: Current knowledge and therapeutic advances.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11818927" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16482553" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16628689" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Anastomotic biliary strictures after liver transplantation: causes and consequences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16382450" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14528211" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Long-term outcomes for patients with post-liver transplant anastomotic biliary strictures treated by endoscopic stent placement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17591473" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17984838" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : A prospective study of standardized nonsurgical therapy in the management of biliary anastomotic strictures complicating liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18702031" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19326412" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Endoscopic treatment for biliary stricture after adult living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23062758" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23473000" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Managing the post-liver transplantation anastomotic biliary stricture: multiple plastic versus metal stents: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20630514" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Endotherapy of postoperative biliary strictures with multiple stents: results after more than 10 years of follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25438291" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Endoscopic retrograde cholangiography for biliary anastomotic strictures after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23580410" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Clinical outcome of progressive stenting in patients with anastomotic strictures after orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24587819" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : A randomized trial of a fully covered self-expandable metallic stent versus plastic stents in anastomotic biliary strictures after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27002446" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Effect of Covered Metallic Stents Compared With Plastic Stents on Benign Biliary Stricture Resolution: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28302527" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation: a prospective, randomized, multicenter trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28455159" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Metal versus plastic stents for anastomotic biliary strictures after liver transplantation: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30258982" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Metallic vs plastic stents to treat biliary stricture after liver transplantation: a systematic review and meta-analysis based on randomized trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32417298" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Fully covered self-expanding metal stents for benign biliary stricture after orthotopic liver transplant: 5-year outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26859556" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Endoscopic management with multiple plastic stents of anastomotic biliary stricture following liver transplantation: long-term results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20189508" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29055929" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Endoscopic Therapy is Effective for Recurrent Anastomotic Biliary Strictures after Orthotopic Liver Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18552573" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Biliary strictures after liver transplantation. Predictive factors for response to endoscopic management and long-term outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19763389" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Long-term outcome of endoscopic and/or percutaneous transhepatic therapy in patients with biliary stricture after orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22467549" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Risk factors and outcomes of failed endoscopic retrograde cholangiopancreatography in liver transplant recipients with anastomotic biliary strictures: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21716179" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Biliary strictures after liver transplantation: is percutaneous treatment indicated?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16628684" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Bile duct strictures after liver transplantation: a changing landscape of the Achilles' heel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12814481" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9512276" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Endoscopic management of biliary strictures in liver transplant recipients: effect on patient and graft survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24560661" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33626248" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17457935" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16952286" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Endoscopic management of biliary complications after adult living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19249040" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21074761" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Predictors of endoscopic treatment outcomes in the management of biliary problems after liver transplantation at a high-volume academic center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23704818" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Biliary complications following liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14575389" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Bile leakage after living donor liver transplantation demonstrated with hepatobiliary scan using 9mTc-PMT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10882963" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Endoscopic management of postoperative biliary complications in orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30959587" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Efficacy of Nasobiliary Tubes and Biliary Stents in Management of Patients with Bile Leak after Liver Transplantation: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32543875" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Endoscopic treatment of biliary complications after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29435318" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Endoscopic management of bile leaks after liver transplantation: An analysis of two high-volume transplant centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10980063" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Endoscopic management of biliary leaks after T-tube removal in liver transplant recipients: nasobiliary drainage versus biliary stenting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18825682" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17335675" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Management of biliary complications following orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18825732" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Bile duct stones and casts after liver transplantation: Different entities but similar prevention strategy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12907345" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18825683" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Biliary cast syndrome following liver transplantation: Predictive factors and clinical outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23601581" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Biliary cast syndrome post-liver transplantation: risk factors and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Sphincter of Oddi Dysfunction after Liver Transplantation: Experience in a High Volume Transplant Center
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29025382" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Biliary Complications in Recipients of Living-Donor Liver Transplant: A Single-Center Review of 120 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27144629" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Rome IV. Gallbladder and Sphincter of Oddi Disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34567561" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : The presence and outcome of biliary sphincter disorders in liver-transplant recipients according to the Rome IV classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17885788" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19938121" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Routine microsurgical biliary reconstruction decreases early anastomotic complications in living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32387205" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Biliary reconstruction and complications in living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17227565" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21254344" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27862815" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Systematic review and meta-analysis of studies of biliary reconstruction in adult living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17139423" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23657086" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : A retrospective study on risk factors associated with failed endoscopic treatment of biliary anastomotic stricture after right-lobe living donor liver transplantation with duct-to-duct anastomosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31436017" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Long-term outcomes of endoscopic treatment for duct-to-duct anastomotic strictures after living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18635177" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Percutaneous transhepatic biliary drainage may serve as a successful rescue procedure in failed cases of endoscopic therapy for a post-living donor liver transplantation biliary stricture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32092770" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : A prospective study of fully covered metal stents for different types of refractory benign biliary strictures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31418477" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Intraductal placement of non-flared fully covered metallic stent for refractory anastomotic biliary strictures after living donor liver transplantation: Long-term results of prospective multicenter trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36998348" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Fully covered metallic stents for anastomotic biliary strictures after living donor liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18505689" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Donor morbidity after living donation for liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29735025" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Status of Adult Living Donor Liver Transplantation in the United States: Results from the Adult-To-Adult Living Donor Liver Transplantation Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22335782" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Complications of living donor hepatic lobectomy--a comprehensive report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21704993" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Complications after ERCP in liver transplant recipients.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
